ICU Management & Practice, ICU Volume 5 - Issue 1 - Spring 2005

Contact

Carol Seroussi

Hospital Products manager

Manuëla Leurent

European Marketing

Communication Planner

Respironics International

Website

www.respironics.com. medicine.umaryland.edu

Correspondence

[email protected]

 

The efficacy of noninvasive ventilation is largely dependent on the reliable performance of patient interfaces. With the Performance Series, our goal is to offer the most comprehensive line of NPPV masks and circuits for EMS and critical care environments.


For example, by incorporating features like an adjustable forehead support, advanced cushion designs, enhanced head strap material in a broad array of styles and sizes – our patient interface selection is compatible with Respironics’ noninvasive therapy devices such as BiPAP®Vision® and Whisper Flow CPAP System.

 

An additional standard elbow (SE) feature makes selected Respironics masks compatible with all existing critical careventilators that operate in noninvasive modes, including Respironics' Esprit Critical Care Ventilator. The Performance Series is designed to help clinicians deliver effective treatment while providing patients’ increased comfort.

 

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and healthcare providers.

 

Respironics markets its products in over 100 countries and employs more than 2,900 associates worldwide. Further information can be found on the company’s website.

«« New ‘Robust’ Treatment for Stroke Uses Genetic Material From Bone Marrow


Your Eyes May Hold Clues to Stroke Risk »»